The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 21140-21152

  Bao, Xingfu ^a   Liu, Yuyan ^a   Han, Guanghong ^a   Zuo, Zhigang ^b   Hu, Min ^a  

^a JILIN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cementoblast; Inhibitor; Root resorption; Sclerostin

Indexed keywords

ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; SCLEROSTIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL TYPE; CEMENTOBLAST; CEMENTUM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; GENE TARGETING; HOMEOSTASIS; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TOOTH DEVELOPMENT; TOOTH DISEASE;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CEMENTOGENESIS; DENTAL CEMENTUM; GLYCOPROTEINS; MICE; OSTEOPROTEGERIN; RANK LIGAND;

EID: 84886259781     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141021140     Document Type: Article

References (44)

1. Bosshardt, D.D.; Selvig, K.A. Dental cementum: The dynamic tissue covering of the root. Periodontol. 2000 1997, 13, 41-75
2. Nanci, A.; Bosshardt, D.D. Structure of periodontal tissues in health and disease. Periodontol. 2000 2006, 40, 11-28.
3. Bosshardt, D.D.; Zalzal, S.; McKee, M.D.; Nanci, A. Developmental appearance and distribution of bone sialoprotein and osteopontin in human and rat cementum. Anat. Rec. 1998, 250, 13-33.
4. Bosshardt, D.D. Are cementoblasts a subpopulation of osteoblasts or a unique phenotype? J. Dent. Res. 2005, 84, 390-406.
5. Ramanathan, C.; Hofman, Z. Root resorption in relation to orthodontic tooth movement. Acta Medica 2006, 49, 91-95.
6. Weltman, B.; Vig, K.W.; Fields, H.W.; Shanker, S.; Kaizar, E.E. Root resorption associated with orthodontic tooth movement: A systematic review. Am. J. Orthod. Dentofac. Orthop. 2010, 137, 462-476.
7. Brezniak, N.; Wasserstein, A. Orthodontically induced inflammatory root resorption. Part ii: The clinical aspects. Angle Orthod. 2002, 72, 180-184.
8. Brezniak, N.; Wasserstein, A. Orthodontically induced inflammatory root resorption. Part i: The basic science aspects. Angle Orthod. 2002, 72, 175-179.
9. Tyrovola, J.B.; Perrea, D.; Halazonetis, D.J.; Dontas, I.; Vlachos, I.S.; Makou, M. Relation of soluble rankl and osteoprotegerin levels in blood and gingival crevicular fluid to the degree of root resorption after orthodontic tooth movement. J. Oral Sci. 2010, 52, 299-311.
10. Jager, A.; Kunert, D.; Friesen, T.; Zhang, D.; Lossdorfer, S.; Gotz, W. Cellular and extracellular factors in early root resorption repair in the rat. Eur. J. Orthod. 2008, 30, 336-345.
11. Owman-Moll, P.; Kurol, J.; Lundgren, D. Repair of orthodontically induced root resorption in adolescents. Angle Orthod. 1995, 65, 403-408; discussion 409-410.
12. Tian, Y.; Huang, L.; Guo, Y.W.; Cao, L.; Wang, Y.T.; Xu, H.; Bai, D. Expression of alkaline phosphatase in immortalized murine cementoblasts in response to compression-force. Saudi Med. J. 2011, 32, 1235-1240.
13. Kim, H.S.; Lee, D.S.; Lee, J.H.; Kang, M.S.; Lee, N.R.; Kim, H.J.; Ko, J.S.; Cho, M.I.; Park, J.C. The effect of odontoblast conditioned media and dentin non-collagenous proteins on the differentiation and mineralization of cementoblasts in vitro. Arch. Oral Biol. 2009, 54, 71-79.
14. Rego, E.B.; Inubushi, T.; Kawazoe, A.; Miyauchi, M.; Tanaka, E.; Takata, T.; Tanne, K. Effect of pge(2) induced by compressive and tensile stresses on cementoblast differentiation in vitro. Arch. Oral Biol. 2011, 56, 1238-1246.
15. Hakki, S.S.; Foster, B.L.; Nagatomo, K.J.; Bozkurt, S.B.; Hakki, E.E.; Somerman, M.J.; Nohutcu, R.M. Bone morphogenetic protein-7 enhances cementoblast function in vitro. J. Periodontol. 2010, 81, 1663-1674.
16. Bozic, D.; Grgurevic, L.; Erjavec, I.; Brkljacic, J.; Orlic, I.; Razdorov, G.; Grgurevic, I.; Vukicevic, S.; Plancak, D. The proteome and gene expression profile of cementoblastic cells treated by bone morphogenetic protein-7 in vitro. J. Clin. Periodontol. 2012, 39, 80-90.
17. Oka, H.; Miyauchi, M.; Sakamoto, K.; Kitagawa, M.; Noguchi, K.; Somerman, M.J.; Takata, T. Prostaglandin e2 inhibits mineralization and enhances matrix metalloproteinase-13 in mature cementoblasts mainly via the ep4 pathway. Arch. Oral Biol. 2008, 53, 243-249.
18. Zhang, H.; Tompkins, K.; Garrigues, J.; Snead, M.L.; Gibson, C.W.; Somerman, M.J. Full length amelogenin binds to cell surface lamp-1 on tooth root/periodontium associated cells. Arch. Oral Biol. 2010, 55, 417-425.
19. Moester, M.J.; Papapoulos, S.E.; Lowik, C.W.; van Bezooijen, R.L. Sclerostin: Current knowledge and future perspectives. Calcif. Tissue Int. 2010, 87, 99-107.
20. Atkins, G.J.; Findlay, D.M. Osteocyte regulation of bone mineral: A little give and take. Osteoporos. Int. 2012, 23, 2067-2079.
21. Van Bezooijen, R.L.; Ten Dijke, P.; Papapoulos, S.E.; Lowik, C.W. Sost/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev. 2005, 16, 319-327.
22. Morse, L.R.; Sudhakar, S.; Lazzari, A.A.; Tun, C.; Garshick, E.; Zafonte, R.; Battaglino, R.A. Sclerostin: A candidate biomarker of sci-induced osteoporosis. Osteoporos. Int. 2013, 24, 961-968.
23. Li, X.; Ominsky, M.S.; Niu, Q.T.; Sun, N.; Daugherty, B.; D'Agostin, D.; Kurahara, C.; Gao, Y.; Cao, J.; Gong, J.; et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J. Bone Miner. Res. 2008, 23, 860-869.
24. Canalis, E. Wnt signalling in osteoporosis: Mechanisms and novel therapeutic approaches. Nat. Rev. Endocrinol. 2013, 9, 575-583.
25. O'Brien, C.A.; Nakashima, T.; Takayanagi, H. Osteocyte control of osteoclastogenesis. Bone 2013, 54, 258-263.
26. Galli, C.; Passeri, G.; Macaluso, G.M. Osteocytes and wnt: The mechanical control of bone formation. J. Dent. Res. 2010, 89, 331-343.
27. Burgers, T.A.; Williams, B.O. Regulation of wnt/β-catenin signaling within and from osteocytes. Bone 2013, 54, 244-249.
28. Zhao, L.; Shim, J.W.; Dodge, T.R.; Robling, A.G.; Yokota, H. Inactivation of lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loading. Bone 2013, 54, 35-43.
29. Taut, A.D.; Jin, Q.; Chung, J.H.; Galindo-Moreno, P.; Yi, E.S.; Sugai, J.V.; Ke, H.Z.; Liu, M.; Giannobile, W.V. Sclerostin antibody stimulates bone regeneration following experimental periodontitis. J. Bone Miner. Res. 2013, doi:10.1002/jbmr.1984.
30. McColm, J.; Hu, L.; Womack, T.; Tang, C.C.; Chiang, A.Y. Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women. J. Bone Miner. Res. 2013, doi: 10.1002/jbmr.2092.
31. Jager, A.; Gotz, W.; Lossdorfer, S.; Rath-Deschner, B. Localization of sost/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J. Periodontal Res. 2010, 45, 246-254.
32. Sutherland, M.K.; Geoghegan, J.C.; Yu, C.; Turcott, E.; Skonier, J.E.; Winkler, D.G.; Latham, J.A. Sclerostin promotes the apoptosis of human osteoblastic cells: A novel regulation of bone formation. Bone 2004, 35, 828-835.
33. Nemoto, E.; Koshikawa, Y.; Kanaya, S.; Tsuchiya, M.; Tamura, M.; Somerman, M.J.; Shimauchi, H. Wnt signaling inhibits cementoblast differentiation and promotes proliferation. Bone 2009, 44, 805-812.
34. Hakki, S.S.; Bozkurt, S.B.; Hakki, E.E.; Belli, S. Effects of mineral trioxide aggregate on cell survival, gene expression associated with mineralized tissues, and biomineralization of cementoblasts. J. Endod. 2009, 35, 513-519.
35. Hakki, S.S.; Nohutcu, R.M.; Hakki, E.E.; Berry, J.E.; Akkaya, M.S.; Somerman, M.J. Dexamethasone and basic-fibroblast growth factor regulate markers of mineralization in cementoblasts in vitro. J. Periodontol. 2005, 76, 1550-1558.
36. Wijenayaka, A.R.; Kogawa, M.; Lim, H.P.; Bonewald, L.F.; Findlay, D.M.; Atkins, G.J. Sclerostin stimulates osteocyte support of osteoclast activity by a rankl-dependent pathway. PLoS One 2011, 6, e25900.
37. Atkins, G.J.; Rowe, P.S.; Lim, H.P.; Welldon, K.J.; Ormsby, R.; Wijenayaka, A.R.; Zelenchuk, L.; Evdokiou, A.; Findlay, D.M. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a mepe-asarm-dependent mechanism. J. Bone Miner. Res. 2011, 26, 1425-1436.
38. Brunkow, M.E.; Gardner, J.C.; van Ness, J.; Paeper, B.W.; Kovacevich, B.R.; Proll, S.; Skonier, J.E.; Zhao, L.; Sabo, P.J.; Fu, Y.; et al. Bone dysplasia sclerosteosis results from loss of the sost gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 2001, 68, 577-589.
39. Van Bezooijen, R.L.; Papapoulos, S.E.; Lowik, C.W. Bone morphogenetic proteins and their antagonists: The sclerostin paradigm. J. Endocrinol. Investig. 2005, 28, 15-17.
40. Winkler, D.G.; Sutherland, M.K.; Geoghegan, J.C.; Yu, C.; Hayes, T.; Skonier, J.E.; Shpektor, D.; Jonas, M.; Kovacevich, B.R.; Staehling-Hampton, K.; et al. Osteocyte control of bone formation via sclerostin, a novel bmp antagonist. EMBO J. 2003, 22, 6267-6276.
41. Kubota, T.; Michigami, T.; Ozono, K. Wnt signaling in bone. Clin. Pediatr. Endocrinol. 2010, 19, 49-56.
42. Lehnen, S.D.; Gotz, W.; Baxmann, M.; Jager, A. Immunohistochemical evidence for sclerostin during cementogenesis in mice. Ann. Anat. 2012, 194, 415-421.
43. Van Bezooijen, R.L.; Bronckers, A.L.; Gortzak, R.A.; Hogendoorn, P.C.; van der Wee-Pals, L.; Balemans, W.; Oostenbroek, H.J.; van Hul, W.; Hamersma, H.; Dikkers, F.G.; et al. Sclerostin in mineralized matrices and van buchem disease. J. Dent. Res. 2009, 88, 569-574.
44. Bustin, S. Transparency of reporting in molecular diagnostics. Int. J. Mol. Sci. 2013, 14, 15878-15884.